Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Babao Dan for Minimal Hepatic Encephalopathy
ChiCTR-IPR-16009588Phase 4Not yet recruiting
- Sponsor
- Shuguang Hospital
- Start
- Dec 2016
- Countries
- 1
01
Overview
Phase 4 trial of Babaodan in hepatic encephalopathy (HE) (3 arms), sponsored by Shuguang Hospital. Primary endpoints: Number connection test, Digit symbol test and 2 more. Planned start Dec 2016; status: not yet recruiting.
02
Drugs
Babaodan
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on ChiCTR-IPR-16009588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009588.